BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

10 articles for M Brune

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Adamantane sulfone and sulfonamide 11-beta-HSD1 Inhibitors.EBI
Abbott Laboratories
Optimization of chromone-2-carboxamide melanin concentrating hormone receptor 1 antagonists: assessment of potency, efficacy, and cardiovascular safety.EBI
Abbott Laboratories
Discovery of orally active butyrolactam 11beta-HSD1 inhibitors.EBI
Abbott Laboratories
Synthesis and biological evaluation of heterocycle containing adamantane 11beta-HSD1 inhibitors.EBI
Abbott Laboratories
Aminopiperidine indazoles as orally efficacious melanin concentrating hormone receptor-1 antagonists.EBI
Abbott Laboratories
Discovery and characterization of aminopiperidinecoumarin melanin concentrating hormone receptor 1 antagonists.EBI
Abbott Laboratories
Identification of ortho-amino benzamides and nicotinamides as MCHr1 antagonists.EBI
Abbott Laboratories
Identification of 2-(4-benzyloxyphenyl)-N- [1-(2-pyrrolidin-1-yl-ethyl)-1H-indazol-6-yl]acetamide, an orally efficacious melanin-concentrating hormone receptor 1 antagonist for the treatment of obesity.EBI
Abbott Laboratories
Discovery of a novel class of orally active, non-peptide angiotensin II antagonists.EBI
Abbott Laboratories
Discovery of 5-[5-fluoro-2-oxo-1,2- dihydroindol-(3Z)-ylidenemethyl]-2,4- dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase.BDB
Sugen